Ask the Doctor/Q&A How much control does a person with Parkinsonโs have over his/her symptoms? One of the key...see more
CLINICAL TRIAL ANNOUNCEMENT
: An Experimental, One-Time Gene Therapy for Parkinsonโs Disease If your response to Parkinsonโs disease medications has...see more
Research Updates

In September, APDA announced funding for cutting-edge research projects for the 2019-2020 academic year totaling $1.7 million....see more
APDA GATHERS WITH GLOBAL PD COMMUNITY

2019 World Parkinson Congress Highlights: A world away, but so close together No matter where we find ourselves โ...see more
Coloring outside the lines of traditional PD therapies
ย New Program Offers Creative Outlet, Improves PD Symptoms ย An innovative new...see more
Creating Connections
Beyond the Doctorโs Visit: Taking Parkinsonโs Care to the Next Level โGame changing.โ Thatโs how Robin...see more
Taking Parkinsonโs education to the farmers market: educating under-served communities
Dr. Lynda Nwabuobi, Movement Disorder Fellow at Columbia Presbyterian...see more
THE AMERICAN PARKINSON DISEASE ASSOCIATION AWARDS FRESH CROP OF RESEARCH GRANTS & NEW DIVERSITY-FOCUSED RESEARCH INITIATIVE
The American Parkinson Disease Association Awards Fresh Crop of Research Grants & New Diversity-Focused Research Initiative From T cells...see more
APDA DIVERSITY IN PD RESEARCH GRANT: ACADEMIC YEAR 2022-2023
Deadline: 03/11/2022ย APPLY HERE Award details One year grant up to a maximum of $75,000 will be awarded to...see more
New medication, Istradefylline, gets approved for Parkinsonโs disease
On August 27, 2019, pharmaceutical company Kyowa Kirin received FDA approval...see more